$ROIV 4 SEC Filings

Filed On	Filing
22 Oct 2026	Form 4: Venker Eric, President & Immunovant CEO Sold 200,000 shares ($7.02M)
20 Oct 2026	Form 4: Gline Matthew, Director Gave up 34,638 shares to cover exercise price or tax ($1.16M)
20 Oct 2026	Form 4: Sukhatme Mayukh, Director Gave up 19,976 shares to cover exercise price or tax ($670K)
05 Oct 2026	Form 4: Epperly Melissa B,, Director Received 17,750 shares by exercise or conversion ($79.2K) · Sold 17,750 shares ($641K)
05 Oct 2026	Form 4: Roivant Sciences Ltd., Director · Arbutus Biopharma Corp Returned 8,967,383 shares to the issuer ($44.8M)
02 Oct 2026	Form 4: Gline Matthew, Director Gave up 76,171 shares to cover exercise price or tax ($2.79M)
02 Oct 2026	Form 4: Sukhatme Mayukh, Director Gave up 46,879 shares to cover exercise price or tax ($1.71M)
02 Oct 2026	Form 4: Venker Eric, President & Immunovant CEO Received 200,000 shares by exercise or conversion ($770K) · Sold 200,000 shares ($7.32M)
02 Oct 2026	Form 4: Torti Frank, President and Vant Chair Acquired 40,309 shares (Exercise Price / Tax Payment) ($1.47M)
22 Sep 2026	Form 4: Pulik Richard, CFO Gave up 2,129 shares to cover exercise price or tax ($84.7K)
22 Sep 2026	Form 4: Humes Jennifer, Chief Accounting Officer Gave up 3,880 shares to cover exercise price or tax ($154K)
18 Sep 2026	Form 4: Gold Daniel Allen, Director Received 5,054 shares as a grant or award · Granted 10,531 Stock Option (Right to Buy)
18 Sep 2026	Form 4: Manchester Keith S, Director Received 5,054 shares as a grant or award · Granted 10,531 Stock Option (Right to Buy)
18 Sep 2026	Form 4: Oren Ilan, Director Received 5,054 shares as a grant or award · Granted 10,531 Stock Option (Right to Buy)
18 Sep 2026	Form 4: Fitzgerald Meghan, Director Received 5,054 shares as a grant or award · Granted 10,531 Stock Option (Right to Buy)
18 Sep 2026	Form 4: Epperly Melissa B,, Director Received 5,054 shares as a grant or award · Granted 10,531 Stock Option (Right to Buy)
18 Sep 2026	Form 4: Momtazee James C, Director Received 5,054 shares as a grant or award · Granted 10,531 Stock Option (Right to Buy)
17 Sep 2026	Form 4: Epperly Melissa B,, Director Sold 4,938 shares ($196K)
17 Sep 2026	Form 4: Fitzgerald Meghan, Director Sold 5,112 shares ($203K)
14 Sep 2026	Form 4: Epperly Melissa B,, Director Gave up 2,179 shares to cover exercise price or tax ($89.2K)

Comments